Profile Pharma Limited, a specialist UK-based pharmaceutical
company, is the marketing authorisation holder for Promixin^® 1 MIU Powder for Nebuliser Solution, for the treatment of susceptible pseudomonal lung infections in patients with cystic fibrosis.

Promixin^® is marketed alongside Respironics’ AAD^® systems.

UK Healthcare professionals

UK Patients and Caregivers

For further information on cystic fibrosis go to www.cftrust.org.uk